BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38538986)

  • 1. Aberrant activated Notch1 promotes prostate enlargement driven by androgen signaling via disrupting mitochondrial function in mouse.
    Kang JW; He JP; Liu YN; Zhang Y; Song SS; Xu QX; Wei SW; Lu L; Meng XQ; Xu L; Guo B; Su RW
    Cell Mol Life Sci; 2024 Mar; 81(1):155. PubMed ID: 38538986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.
    Jin BR; Kim HJ; Na JH; Lee WK; An HJ
    J Adv Res; 2024 Mar; 57():135-147. PubMed ID: 37061215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
    Simanainen U; McNamara K; Gao YR; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naftopidil enantiomers suppress androgen accumulation and induce cell apoptosis via the UDP-glucuronosyltransferase 2B15 in benign prostate hyperplasia.
    Zhan H; Zhang S; Li L; Chen Z; Cai Y; Huang J; Wu D; Huang B; Wu B; Liu X
    J Steroid Biochem Mol Biol; 2022 Jul; 221():106117. PubMed ID: 35504423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-κB and androgen receptor variant expression correlate with human BPH progression.
    Austin DC; Strand DW; Love HL; Franco OE; Jang A; Grabowska MM; Miller NL; Hameed O; Clark PE; Fowke JH; Matusik RJ; Jin RJ; Hayward SW
    Prostate; 2016 Apr; 76(5):491-511. PubMed ID: 26709083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia.
    Prins GS; Jung MH; Vellanoweth RL; Chatterjee B; Roy AK
    Dev Genet; 1996; 18(2):99-106. PubMed ID: 8934871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
    Nicholson TM; Ricke WA
    Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor.
    Zhang B; Kwon OJ; Henry G; Malewska A; Wei X; Zhang L; Brinkley W; Zhang Y; Castro PD; Titus M; Chen R; Sayeeduddin M; Raj GV; Mauck R; Roehrborn C; Creighton CJ; Strand DW; Ittmann MM; Xin L
    Mol Cell; 2016 Sep; 63(6):976-89. PubMed ID: 27594448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.
    Chatterjee B
    Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant mitoquinone suppresses benign prostatic hyperplasia by regulating the AR-NLRP3 pathway.
    Jin BR; Lim CY; Kim HJ; Lee M; An HJ
    Redox Biol; 2023 Sep; 65():102816. PubMed ID: 37454529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells.
    Song IS; Jeong YJ; Kim J; Seo KH; Baek NI; Kim Y; Kim CS; Jang SW
    Cell Mol Life Sci; 2020 Nov; 77(22):4663-4673. PubMed ID: 31894360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer.
    Bauman DR; Steckelbroeck S; Peehl DM; Penning TM
    Endocrinology; 2006 Dec; 147(12):5806-16. PubMed ID: 16959841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis.
    Jin BR; An HJ
    Aging (Albany NY); 2020 Feb; 12(3):2142-2155. PubMed ID: 32018227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoralea corylifolia L. extract ameliorates benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis.
    Kim HJ; Jin BR; An HJ
    J Ethnopharmacol; 2021 Jun; 273():113844. PubMed ID: 33485982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
    de Jong FH; Reuvers PJ; Bolt-de Vries J; Mulder E; Blom JH; Schroeder FH
    J Steroid Biochem Mol Biol; 1992 Mar; 42(1):49-55. PubMed ID: 1373073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal androgen and hedgehog signaling regulates stem cell niches in pubertal prostate development.
    Olson AW; Le V; Wang J; Hiroto A; Kim WK; Lee DH; Aldahl J; Wu X; Kim M; Cunha GR; You S; Sun Z
    Development; 2021 Oct; 148(19):. PubMed ID: 34427305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH-PRO extract alleviates benign prostatic hyperplasia via ROS-mediated activation of PARP/caspase 3 and inhibition of FOXO3a/AR/PSA signaling in vitro and in vivo.
    Park JE; Shin WC; Lee HJ; Yoon D; Sim DY; Ahn CH; Park SY; Shim BS; Park SJ; Kim KS; Park GD; Kim SH; Lee DY
    Phytother Res; 2023 Feb; 37(2):452-463. PubMed ID: 36122906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages affect immune inflammation and proliferation in benign prostatic hyperplasia via androgen receptor and CD40/CD40L signaling pathway.
    Yang M; Xu Z; Zhuang Z
    Tissue Cell; 2020 Jun; 64():101343. PubMed ID: 32473708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.